Acreage Holdings Inc (ACRDF)
0.2902
-0.04
(-12.85%)
USD |
OTCM |
Jun 21, 16:00
Acreage Holdings Enterprise Value: 234.49M for June 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 21, 2024 | 234.49M |
| June 20, 2024 | 239.51M |
| June 18, 2024 | 238.28M |
| June 17, 2024 | 240.04M |
| June 14, 2024 | 234.63M |
| June 13, 2024 | 234.49M |
| June 12, 2024 | 242.10M |
| June 11, 2024 | 239.16M |
| June 10, 2024 | 233.90M |
| June 07, 2024 | 244.45M |
| June 06, 2024 | 244.60M |
| June 05, 2024 | 246.42M |
| June 04, 2024 | 250.18M |
| June 03, 2024 | 251.23M |
| May 31, 2024 | 248.08M |
| May 30, 2024 | 250.65M |
| May 29, 2024 | 258.83M |
| May 28, 2024 | 244.81M |
| May 24, 2024 | 251.82M |
| May 23, 2024 | 251.82M |
| May 22, 2024 | 252.28M |
| May 21, 2024 | 253.57M |
| May 20, 2024 | 253.57M |
| May 17, 2024 | 253.57M |
| May 16, 2024 | 255.67M |
| Date | Value |
|---|---|
| May 15, 2024 | 257.89M |
| May 14, 2024 | 252.28M |
| May 13, 2024 | 258.83M |
| May 10, 2024 | 257.66M |
| May 09, 2024 | 254.41M |
| May 08, 2024 | 258.83M |
| May 07, 2024 | 251.82M |
| May 06, 2024 | 258.83M |
| May 03, 2024 | 254.15M |
| May 02, 2024 | 244.10M |
| May 01, 2024 | 243.64M |
| April 30, 2024 | 265.84M |
| April 29, 2024 | 252.99M |
| April 26, 2024 | 252.05M |
| April 25, 2024 | 244.63M |
| April 24, 2024 | 247.14M |
| April 23, 2024 | 247.14M |
| April 22, 2024 | 247.14M |
| April 19, 2024 | 245.65M |
| April 18, 2024 | 242.99M |
| April 17, 2024 | 242.17M |
| April 16, 2024 | 243.21M |
| April 15, 2024 | 245.53M |
| April 12, 2024 | 257.25M |
| April 11, 2024 | 259.57M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
200.32M
Minimum
Jun 28 2023
583.44M
Maximum
Jan 14 2021
308.23M
Average
284.63M
Median
Feb 07 2022
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.982M |
| Palatin Technologies Inc | 20.48M |
| iBio Inc | 26.49M |
| Theriva Biologics Inc | -11.16M |
| Oragenics Inc | 6.100M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -27.98M |
| Revenue (Quarterly) | 45.30M |
| Total Expenses (Quarterly) | 68.36M |
| EPS Diluted (Quarterly) | -0.24 |
| Gross Profit Margin (Quarterly) | -3.30% |
| Profit Margin (Quarterly) | -61.76% |
| Earnings Yield | -248.1% |
| Normalized Earnings Yield | -189.29 |